News
New vaccine designed to help fight colorectal, pancreatic cancer shows promising results: Study
A new vaccine designed to combat cancer cells in patients with colorectal and pancreatic cancer showed promising results in its phase 1 trial. Researchers at the University of California said 21 out of 25 patients generated an immune response to cancer cells.
New Phase I trial data finds that people who responded to ELI-002 survived longer and stayed cancer-free longer than usual.
Researchers found patients with pancreatic cancer and bowel cancer survived more than two years after receiving the vaccine ...
Black and Hispanic people are more likely to be diagnosed with pancreatic cancer and more likely to die from it. Now, one drug may help fix this.
A novel cancer vaccine that stimulates the immune system to target one of the most common cancer-driving mutations has shown ...
In fact, only 10 per cent of patients are diagnosed in time for life-saving surgery. But a potential vaccine is now ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback